Kingworld Medicines Group Limited
HKSE: 1110.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Li Sheng Zhao
- Employees
- 972
- Headquarters
- Shenzhen, China
- IPO year
- 2010
- Market cap
- HK$277.2M
- Website
- https://www.kingworld.com.cn
Loading 1110…
Loading profile data…Frequently asked questions about 1110
What does Kingworld Medicines Group Limited (1110.HK) do?
Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products. The company also supplies pharmaceutical, healthcare, general foodstuffs, and medical products. It offers products for various functional categories, such as cough and phlegm relieving, gastrointestinal, vitamin,...
Where does 1110.HK trade?
Kingworld Medicines Group Limited (1110.HK) trades on the Hong Kong Stock Exchange.
What sector is 1110.HK in?
Kingworld Medicines Group Limited (1110.HK) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Kingworld Medicines Group Limited?
Li Sheng Zhao is the chief executive officer of Kingworld Medicines Group Limited (1110.HK).
Where is Kingworld Medicines Group Limited headquartered?
Kingworld Medicines Group Limited is headquartered in China.
Does 1110.HK pay a dividend?
Yes — Kingworld Medicines Group Limited (1110.HK) paid a trailing twelve-month dividend of HKD 0.03 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1110.HK go public?
Kingworld Medicines Group Limited (1110.HK) completed its initial public offering in 2010.